Drawing for HUMMINGBIRD BIOSCIENCE

USPTO serial 79344027

HUMMINGBIRD BIOSCIENCE

Reviewed by CopyMark Law Group

Reg. 7764191Status 700Registered
Filing date
Status date
Registration date
Apr 22, 2025
Examiner
STEINPFAD, SARAH E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HUMMINGBIRD BIOSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maren C. Perry

Maren C. Perry King & Spalding LLP1185 Avenue of the AmericasNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, diagnosis, and treatment of oncological and immune system diseases for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical and biological preparations for use in the treatment of biological disorders for oncological and immune system diseases; pharmaceutical preparations for therapeutic interventions, namely, therapeutic agents to treat oncological and immune systems diseases ; biological preparations for the treatment of biological disorders for oncological and immune system diseases; anti-cancer drugs; biological preparations for the treatment of cancer; immunological antibodies for medical use; monoclonal antibodies for medical use, monoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; reagents for use in the development of monoclonal antibodies for medical purposesACTIVE—
042Medical research, medical research services; scientific research for medical purposes in the area of cancerous drugs; biomedical research services; drug discovery services; scientific and technological research and design in the field of medical biotechnology; scientific and technological industrial analysis and research services; scientific research in the development of new therapies to treat biological disorders; scientific research for the medical purposes in the area of cancerous diseases; research and development services in the field of antibodiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 30, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 6, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 6, 2025FIMPFINAL DISPOSITION PROCESSED—
Jul 22, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 22, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 22, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2025PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 7, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2024ALIEASSIGNED TO LIE—
Jun 11, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 11, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 15, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 25, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 22, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Dec 22, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Dec 22, 2023CNSLSUSPENSION LETTER WRITTEN—
Dec 6, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 6, 2023DOCKASSIGNED TO EXAMINER—
Nov 4, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 3, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 23, 2023RFNTREFUSAL PROCESSED BY IB—
May 4, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 4, 2023RFRRREFUSAL PROCESSED BY MPU—
Apr 26, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 26, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 26, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 26, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 17, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2023DOCKASSIGNED TO EXAMINER—
Jul 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 1, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance